Who Owns RLMD?

Relmada Therapeutics, Inc. — Institutional Ownership & 13F Holdings

$7.13

+0.11 (+1.56%)

Market Cap

$528.7M

Shares Outstanding

73,333,622

Institutional Holders

44

Total Inst. Value

$1.7M

% of Float Held

10.3%

QoQ Holder Change

-37

Institutional data as of Q1 2025

New Positions

10

Closed Positions

13

Increased

3

Decreased

14

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1ACADIAN ASSET MANAGEMENT LLC$329K1,227,928
2VANGUARD GROUP INC$325K1,208,075
3BlackRock, Inc.$153K566,905
4Palo Alto Investors LP$134K495,146
5GEODE CAPITAL MANAGEMENT, LLC$81K301,883
6TWO SIGMA ADVISERS, LP$78K288,000
7AdvisorShares Investments LLC$76K276,514
8DEUTSCHE BANK AG\$61K224,846
9TWO SIGMA INVESTMENTS, LP$46K170,544
10PARSONS CAPITAL MANAGEMENT INC/RI$44K163,336

Biggest Buyers & Sellers This Quarter

Top Sellers

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold RLMD?

As of Q1 2025, 44 institutional investors report holding RLMD (Relmada Therapeutics, Inc.) in their 13F filings.

What percentage of Relmada Therapeutics, Inc. is owned by institutions?

Institutional investors hold approximately 10.3% of Relmada Therapeutics, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most RLMD?

The largest institutional holder of RLMD is ACADIAN ASSET MANAGEMENT LLC with $329K in shares.

Are institutions buying or selling RLMD?

This quarter, 10 institutions opened new positions in RLMD and 13 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.